Faricimab lacks proof of added benefit over comparator therapies for macular edema
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...
Tag: Visual Impairment
Ciliopathies: A new understanding of the role of the NSL complex
The non-specific lethal (NSL) complex is a chromatin-associated factor that has been shown to regulate the expression of thousands of ...
Specific form of age-related macular degeneration linked to cardiovascular disease and stroke risk
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are ...
